Compounds > medroxyprogesterone acetate
Page last updated: 2024-08-17

medroxyprogesterone acetate and HPV Infection

medroxyprogesterone acetate has been researched along with HPV Infection in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Balogh, KK; Brendle, SA; Christensen, ND; Cladel, NM; Cooper, T; Hu, J; Li, JJ; Shearer, DA; Walter, V1
Baik, S; Chung, SH; Mehta, FF1
Feng, Q; Harris, TG; Kiviat, NB; Koutsky, LA; Kulasingam, SL; Miller, L; Schwartz, SM1
Datta, SD; Ghanem, KG; Hagensee, M; Hsu, K; Kerndt, P; Koutsky, LA; Shlay, JC; Unger, ER1

Other Studies

4 other study(ies) available for medroxyprogesterone acetate and HPV Infection

ArticleYear
Depo Medroxyprogesterone (DMPA) Promotes Papillomavirus Infections but Does Not Accelerate Disease Progression in the Anogenital Tract of a Mouse Model.
    Viruses, 2022, 05-06, Volume: 14, Issue:5

    Topics: Animals; Contraceptive Agents; Disease Models, Animal; Disease Progression; Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Nude; Papillomavirus Infections

2022
Medroxyprogesterone Acetate Prevention of Cervical Cancer through Progesterone Receptor in a Human Papillomavirus Transgenic Mouse Model.
    The American journal of pathology, 2019, Volume: 189, Issue:12

    Topics: Animals; Antineoplastic Agents, Hormonal; Female; Humans; Medroxyprogesterone Acetate; Mice; Mice, Inbred CBA; Mice, Transgenic; Papillomaviridae; Papillomavirus Infections; Receptors, Progesterone; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms

2019
Depot-medroxyprogesterone acetate and combined oral contraceptive use and cervical neoplasia among women with oncogenic human papillomavirus infection.
    American journal of obstetrics and gynecology, 2009, Volume: 200, Issue:5

    Topics: Adolescent; Adult; Biopsy; Case-Control Studies; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Papillomavirus Infections; Risk Factors; Tumor Virus Infections; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Young Adult

2009
The association of current hormonal contraceptive use with type-specific HPV detection.
    Sexually transmitted infections, 2011, Volume: 87, Issue:5

    Topics: Adolescent; Adult; Aged; Coitus; Contraceptive Agents, Female; Cross-Sectional Studies; Female; Human papillomavirus 16; Humans; Medroxyprogesterone Acetate; Middle Aged; Papillomavirus Infections; Risk Factors; Sentinel Surveillance; Sexual Partners; Uterine Cervical Dysplasia; Young Adult

2011